Boardroom Alpha
10-K primary document
AORT · Annual Report (Form 10-K) · Filed February 18, 2026

Artivion Inc10-K exhibit

aort-20251231xexx211.htm
Document

Exhibit 21.1

SUBSIDIARIES OF ARTIVION, INC.

Subsidiary

Jurisdiction
Artivion Chile SpA
Chile
Artivion Colombia SAS
Colombia
Artivion Cyprus Limited
Cyprus
Artivion EMEA GmbH
Germany
Artivion France S.A.S.
France
Artivion Hellas Single Member Ltd.
Greece
Artivion Hong Kong, Limited
Hong Kong
Artivion India Private Limited
India
Artivion Italy s.r.l.
Italy
Artivion LATAM Holdings Spain, SLU
Spain
Artivion Malaysia, Sdn. Bhd.
Malaysia
Artivion México, S.A. de C.V.Mexico
Artivion New Zealand
New Zealand
Artivion Polska Sp. z.o.o.
Poland
Artivion Spain, s.r.l.Spain
Artivion Taiwan Co. Limited
Taiwan
Artivion UK Ltd.
England and Wales
Ascyrus Medical GmbH
Germany
Ascyrus Medical LLC
Florida
AuraZyme Pharmaceuticals, Inc.
Florida
CryoLife Asia Pacific, PTE. Ltd
Singapore
CryoLife Beijing Medical Device Ltd.
China
CryoLife Canada, Inc.
Canada
CryoLife Germany HoldCo GmbH
Germany
CryoLife Germany TopCo GmbH
Germany
CryoLife International, Inc.
Florida
CryoLife Korea Co., Ltd.
Korea
CryoLife Medical (Australia) Co. Pty, Ltd.
Australia
CryoLife Medical (Thailand) Co., Ltd.
Thailand
CryoLife Vietnam Co., Ltd.
Vietnam
Jolly Buyer Acquisition GmbH
Switzerland
JOTEC do Brasil Ltda.
Brazil
JOTEC GmbH
Germany
JOTEC Sales GmbH
Switzerland
JOTEC UK Ltd.
England
On-X Life Technologies Holdings, Inc.
Delaware
On-X Life Technologies, Inc.
Delaware
Valve Special Purpose Co., LLC
Delaware

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer